
FORM 8-K General Information This section provides an overview of the Form 8-K filing, including general information about the registrant and the filing's purpose Filing Details and Registrant Information This section provides the general filing information for the Form 8-K, including the registrant's details, incorporation state, and securities registration information - The report date is August 7, 2025, filed by Intelligent Bio Solutions Inc., incorporated in Delaware1 Registered Securities Information | Title of each class | Trading Symbol(s) | Name of each exchange on which registered | | :----------------------- | :---------------- | :---------------------------------------- | | Common Stock, $0.01 par value | INBS | The Nasdaq Stock Market LLC | - The registrant, Intelligent Bio Solutions Inc., is an emerging growth company2 Item 2.02 Results of Operations and Financial Condition This section details the preliminary, unaudited financial results for the fiscal fourth quarter Preliminary Revenue Announcement Intelligent Bio Solutions Inc. announced preliminary, unaudited revenue results for the fiscal fourth quarter ended June 30, 2025, via a press release furnished as Exhibit 99.1 - On August 7, 2025, Intelligent Bio Solutions Inc. issued a press release announcing preliminary, unaudited revenue results for the fiscal fourth quarter ended June 30, 20253 - The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K3 - The information in this report, including the exhibit, is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 19334 Item 9.01 Financial Statements and Exhibits This section lists all financial statements and exhibits included in the Form 8-K filing Exhibits Filed This section lists the exhibits accompanying the Form 8-K filing, which include the press release and the interactive data file List of Exhibits | No. | Description | | :-- | :------------------------------------ | | 99.1 | Press release dated August 7, 2025 | | 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | SIGNATURES This section contains the official signatures confirming the authenticity and submission of the report Report Sign-off The report was duly signed on behalf of Intelligent Bio Solutions Inc. by its Chief Financial Officer - The report was signed on August 7, 20258 - Spiro Sakiris, Chief Financial Officer, signed the report on behalf of Intelligent Bio Solutions Inc8